However, the opposite error is equally problematic: assuming that every incidental lung nodule is cancer. Many nodules are benign, and further assessment is needed to determine their significance.
Public health information should help people understand both sides of this issue.
Screening is not the same as universal testing
Screening tests are designed for people who do not have symptoms but meet particular risk criteria. Diagnostic tests, by contrast, investigate symptoms or abnormalities that have already been identified.
For eligible individuals, low-dose CT screening can reduce the risk of dying from lung cancer. But indiscriminate imaging of everyone is not recommended because it can lead to false alarms, unnecessary procedures, and exposure to medical risks.
Anyone concerned about lung cancer should discuss their personal risk factors with a qualified healthcare professional. People who have persistent respiratory symptoms should seek medical evaluation rather than waiting for a screening appointment.
Public health decisions should be guided by evidence, not by fear generated by an alarming headline.
